ʻaoʻao_head_bg

Nā huahana

ʻO ka waika Salvianolic D

ʻO ka wehewehe pōkole:

Ka inoa maʻamau: salvianolic acid D

Ka inoa Pelekane: salvianolic acid D

Ka helu CAS: 142998-47-8

Kaumaha Molekala: 418.351

Māmā: 1.6 ± 0.1 g / cm3

Puni paila: 786.9 ± 60.0 ° C ma 760 mmHg

Ke Kumu Molekala: C20H18O10

Lae hehee: N / A

MSDS: N/A

Kaila Uila: 280.2 ± 26.4 ° C


Huahana Huahana

Huahana Huahana

ʻO ka hoʻohana ʻana i ka Salvianolic Acid D

ʻO ka waika Salvianolic D kahi hui me ka hana antiplatelet i hoʻokaʻawale ʻia mai Salvia miltiorrhaza.

Ka inoa o ka waika Salvianolic D

Inoa Pākē: Salvianolic acid D

Inoa Pelekania: (2R)-2-({(2E)-3-[2-(Carboxymethyl)-3,4-dihydroxyphenyl]-2-propenoyl}oxy)-3-(3,4-dihydroxyphenyl)propanoic acid

Bioactivity o Salvianolic Acid D

wehewehe:ʻO ka salvianolic acid D he hui me ka hana antiplatelet i hoʻokaʻawale ʻia mai Salvia miltiorrhiza.

Nā waeʻano pili:kahua noiʻi > > ʻē aʻe
Alanui hōʻailona > > ʻē aʻe > > ʻē aʻe

Kuhikuhi:[1] Ai CB, et al.Salvianolic Acids D a me E: ʻElua New Depsides mai Salvia miltiorrhiza.Planta Med.1992 Apr;58(2):197-9.
ʻO Chen Y, et al.He Platelet/CMC i hui pū ʻia me UPLC-QTOF-MS/MS offline no ka nānā ʻana i nā ʻāpana hana antiplatelet mai ka ʻāpana wai o Danshen.J Pharm Biomed Anal.2016 Jan 5;117:178-83.

Nā waeʻano pili:kahua noiʻi > > ʻē aʻe
Alanui hōʻailona > > ʻē aʻe > > ʻē aʻe

Kuhikuhi:[1].Ai CB, et al.Salvianolic Acids D a me E: ʻElua New Depsides mai Salvia miltiorrhiza.Planta Med.1992 Apr;58(2):197-9.
ʻO Chen Y, et al.He Platelet/CMC i hui pū ʻia me UPLC-QTOF-MS/MS offline no ka nānā ʻana i nā ʻāpana hana antiplatelet mai ka ʻāpana wai o Danshen.J Pharm Biomed Anal.2016 Ian 5;117:178-83.

Nā waiwai kino o ka ʻakika Salvianolic D

Māmā: 1.6 ± 0.1 g / knm3

Puni paila: 786.9 ± 60.0 ° C ma 760 mmHg

Ke Kumu Molekala: C20h18o10

Kaumaha Molekala: 418.351

Kaila Uila: 280.2 ± 26.4 ° C

Nuipa pololei: 418.089996

LogP: 0.98

Pumi mahu: 0.0 ± 2.9 mmHg ma 25 ° C

Hōʻike Hōʻikeʻike: 1.717

ʻO ka inoa Pelekane o Salvianolic Acid D

(2R)-2-({(2E)-3-[2-(Carboxymethyl)-3,4-dihydroxyphenyl]-2-propenoyl}oxy)-3-(3,4-dihydroxyphenyl)propanoic acid

Benzenepropanoic acid, α-[[(2E)-3-[2-(carboxymethyl)-3,4-dihydroxyphenyl]-1-oxo-2-propen-1-yl]oxy]-3,4-dihydroxy-, ( αR)-

ʻO Jiangsu Yongjian Pharmaceutical Technology Co., Ltd.

ʻO Jiangsu Yongjian Pharmaceutical Technology Co., Ltd., i hoʻokumu ʻia ma Malaki 2012, he ʻoihana ʻenehana kiʻekiʻe e hoʻohui ana i ka R&D, ka hana a me ke kūʻai aku.Hoʻohana nui ʻia ia i ka hana ʻana, hana maʻamau a me ka hoʻomohala ʻana i ke kaʻina hana o nā mea ikaika o nā huahana kūlohelohe, nā mea kuhikuhi lāʻau lapaʻau Kina kuʻuna a me nā haumia lāʻau.Aia ka hui ma China Pharmaceutical City, Taizhou City, Jiangsu Province, me kahi kumu hana 5000 square meter a me kahi kumu 2000 square meter R & D.Hoʻohana nui ia i nā keʻena noiʻi ʻepekema nui, nā kulanui a me nā ʻoihana hana ʻāpana decoction a puni ka ʻāina.

I kēia manawa, ua hoʻomohala mākou ma mua o 1500 mau ʻano o nā reagents kūlohelohe, a hoʻohālikelike ʻia a hoʻohālikelike ʻia ma mua o 300 mau ʻano mea kuhikuhi, hiki ke hoʻokō piha i nā pono nānā i kēlā me kēia lā o nā keʻena noiʻi ʻepekema nui, nā hale hana kulanui a me nā ʻāpana decoction.

Ma muli o ke kumu o ka manaʻoʻiʻo maikaʻi, manaʻolana ka hui e hui pū me kā mākou mea kūʻai.ʻO kā mākou pahuhopu ka lawelawe ʻana i ka hana hou o ka lāʻau lapaʻau Kina.

ʻO ka pāʻoihana maikaʻi o ka hui

1. R & D, hana a kūʻai aku i nā mea hoʻohālikelike kemika o ka lāʻau lapaʻau Kina;

2. Hoʻopilikino ʻia ka lāʻau lapaʻau Kina kuʻuna monomer e like me nā ʻano mea kūʻai aku

3. E noiʻi e pili ana i ke kūlana maikaʻi a me ka hoʻomohala ʻana o ka lāʻau lapaʻau Kina (mea kanu).

4. Hoʻohui ʻenehana, hoʻololi a me ka noiʻi a me ka hoʻomohala lāʻau hou.


  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou